missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18515740

LMO2 Antibody (LMO2/1971), DyLight 680, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-08268FR

4768.00 SEK valid until 2025-03-28
Use promo code "25306" to get your promotional price.

Product Code. 18515740

  • 5960.00 SEK / 100µL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

LMO2 Monoclonal antibody specifically detects LMO2 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LMO2
Monoclonal
DyLight 680
Cysteine-rich protein TTG-2, LIM domain only 2 (rhombotin-like 1), LIM domain only protein 2, LMO-2, RBTN2rhombotin-2, RBTNL1rhombotin-like 1, RHOM2T-cell translocation protein 2, T-cell translocation gene 2, TTG2rhombotin 2
Recombinant human LMO2 protein fragment (around aa 23-140) (exact sequence is proprietary) (Uniprot: P25791)
100 μg
Angiogenesis, Cancer
4005
Store at 4°C in the dark.
IgG2b κ
Western Blot, Flow Cytometry, Immunohistochemistry (Paraffin)
LMO2/1971
50mM Sodium Borate
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.